Reportlinker.com

LONDON, UNITED KINGDOM--(Marketwire - Oct. 9, 2008) - Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.

US Cardiac Implants Market

http://www.reportlinker.com/p096399/US-Cardiac-Implants-Market.html

US demand to reach $16.4 billion in 2012

US demand for cardiac implants will increase 8.8 percent annually to $16.4 billion in 2012. Evolving demographic and epidemiological patterns, along with the introduction of new and improved products, will promote growth. Based on aging population trends, the number of persons afflicted with one or more heart conditions is forecast to reach 73 million in 2012, up 1.7 percent per year from 2007. Implants are more effective than pharmaceuticals in treating, managing or preventing such cardiovascular disorders as arrhythmias, congestive heart failure, myocardial infarction, peripheral artery disease, stroke and valvular heart disease.

The market for cardiac implants is expected to recover from a sharp decline in coronary drug-eluting stent sales that began in mid-2006 and continued into the fourth quarter of 2007. This decline was due to a number of reports that linked the devices to a slightly greater risk of thrombosis in some post-angioplasty patients. Although the reported risk was only onehalf of one percent greater than for heart patients who received alternative therapies (i.e., angioplasty with bare-metal stents, coronary bypass surgery, medications), it prompted many physicians to discontinue using drug-eluting stents. This trend will change as new generation drug-eluting stents with smaller struts and a greatly reduced risk of complications reach the market over the next year.

ICDs, CRT devices will remain dominant types

Cardiac implants extend into several product groups. Implantable cardioverter defibrillators (ICDs) and related cardiac resynchronization therapy (CRT) devices together with their accessories generate the largest demand, followed by various types of stents. These two product groups will continue to lead cardiac implant sales based on new product introductions, widening eligibility for private and public health insurance coverage, expanding numbers of new patients, and diminishing safety concerns. Providing the most effective therapy for bradycardia, pacemakers and accessories will continue to serve a large, expanding US market. However, growth opportunities for these devices will decelerate over the long term as they have already achieved a high level of market penetration.

Heart-related grafts will provide strong growth opportunities as improvements in stenting systems create new safe and effective devices for treating aortic aneurysms, peripheral arterial diseases and stroke. Demand for heart valves will benefit from advances in tissue engineering, which will improve the safety, performance and longevity of animalderived xenografts. Heart valve repair products, consisting of annuloplasty rings and bands, will also fare well in the marketplace as new cardiac diagnostics enable valvular heart diseases to be detected in earlier stages before complete valve replacement becomes necessary. Less favorably, strong growth in the market for tissue valves and valve repair products will be partially offset by decreasing sales of mechanical valves.

Demand for embolic protection devices will rise at a strong pace as many more heart patients undergo procedures that pose an elevated risk of deep vein thrombosis and embolisms. The market for ventricular-assist devices will continue to grow moderately, spurred by widening applications in the management of pretransplant and late-stage heart conditions. Based on their ability to detect heart attack symptoms earlier and save lives, implantable heart monitors will register strong sales growth over the long term.

Study coverage

Cardiac Implants is a new industry study that presents historical demand data (1997, 2002, 2007) plus forecasts for 2012 and 2017 for cardiac implant products by type and indication. The study also assesses evolving research and development, details company market shares and profiles 20 competitors in the US industry.

INTRODUCTION
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
General
Macroeconomic Trends
Demographic Patterns
Health Insurance Trends
Medical Conditions
Acute Conditions
Chronic Conditions
National Health Expenditures
Medical Providers
Acute Care Hospitals
Outpatient Clinics
Skilled Nursing Homes
Physicians
Home Health Care Organizations
Patient Activity
Acute Care Hospital Admissions
Surgical Procedures
Outpatient Episodes
Home Health Care Visits
Medical Product Markets
III. CARDIAC IMPLANT OVERVIEW
General
Cardiovascular Conditions
Coronary Heart Disease
Heart Rhythm Disorders
Peripheral Arterial Disease (PAD)
Valvular Heart Disease
Stroke
Congestive Heart Failure (CHF)
Congenital Heart Defects
Cardiac Implant Procedures
Cardiac Implant Market Trends
Regulatory Factors
Demand Patterns
Product Groups
Indications
US Trade
International Markets
IV. PACING DEVICES
General
Demand Patterns & Projections
Producers & Market Share
Implantable Cardioverter Defibrillators (ICDs)
Technology 


Components & Design
Functions
Clinical Data

Producers & Products 


Medtronic
Boston Scientific
St. Jude Medical

Cardiac Resynchronization Therapy (CRT) Devices
Technology
Producers & Products
Implantable Cardiac Pacemakers (ICPs)
Technology
Producers & Products 


Medtronic
St. Jude Medical
Boston Scientific

Pacing Leads
Technology
Producers & Products 


Pacemaker Leads
ICD Leads
CRT Leads

Pacing Device Batteries
V. CARDIAC STENTS & RELATED IMPLANTS
General
Demand Patterns & Projections
Producers & Market Share
Coronary Stents
Drug-Eluting Stents
Bare-Metal Stents
Peripheral Stents
Endovascular Stent-Grafts 


Medtronic
ANCURE
Other Endovascular Stent-Grafts

Renal & Related Stents
Femoral & Related Stents
Carotid Stents
Stent-Related Implants
Synthetic Grafts 


Vascular Grafts
Peripheral Grafts

Vena Cava Filters
VI. STRUCTURAL CARDIAC IMPLANTS
General
Demand Patterns & Projections
Producers & Market Share
Heart Valves & Accessories
Product Overview
Tissue Heart Valves 


Types of Tissue Heart Valves
Producers & Products

Mechanical Heart Valves 


Design
Producers & Products

Heart Valve Repair Products
Ventricular-Assist Devices
Technology
Producers & Products
Implantable Heart Monitors
Insertable Loop Recorders (ILRs)
Implantable Hemodynamic Monitors
VII. INDUSTRY STRUCTURE
General
Market Share
Competitive Strategies
Mergers & Acquisitions
Licensing & Related Agreements
Research & Development
Marketing & Distribution
Manufacturing Activities
Company Profiles
Abbott Laboratories
Abiomed Incorporated
Angiotech Pharmaceuticals Incorporated
Arbor Surgical Technologies Incorporated
Bard (CR) Incorporated
Biophan Technologies Incorporated
Boston Scientific Corporation
Braun (B.) Melsungen AG
CarboMedics Incorporated, see Sorin SpA
Conor Medsystems LLC, see Johnson & Johnson
Cook Group Incorporated
Cordis Corporation, see Johnson & Johnson
Core Valve Incorporated
Edwards Lifesciences Corporation
Endologix Incorporated
Gore (WL) & Associates Incorporated
Johnson & Johnson
Medtronic Incorporated
Myotech LLC, see Biophan Technologies Incorporated
Sorin SpA
St. Jude Medical Incorporated
Terumo Corporation
Thoratec Corporation
Ventracor Limited
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY
Summary Table
SECTION II -- MARKET ENVIRONMENT
1 Macroeconomic Indicators
2 Population by Age Group
3 Health Insurance Coverage of the US Population
4 Acute Conditions by Type
5 Chronic Conditions by Type
6 National Health Expenditures by Type & Source
7 Medical Providers by Type
8 Patient Activity by Type
9 Medical Product Demand
SECTION III -- CARDIAC IMPLANT OVERVIEW
1 Cardiac Implant Market Indicators
2 Cardiovascular Conditions by Type
3 Cardiac Implant Procedures by Type
4 Cardiac Implant Market, 1997-2007
5 Cardiac Implant Demand by Product Group
6 Cardiac Implant Demand by Indication
7 US Trade in Cardiac Implants
8 World Cardiac Implant Demand by Region
SECTION IV -- PACING DEVICES
1 Pacing Device Demand by Product Group
2 Implantable Cardioverter Defibrillator (ICD) Demand by Type
3 Cardiac Resynchronization Therapy (CRT) Device Demand
4 Implantable Cardiac Pacemaker Demand by Type
5 Pacing Lead Demand by Type
SECTION V -- STENTS & RELATED IMPLANTS
1 Cardiac Stent & Related Implant Demand by Product Group
2 Coronary Stent Demand by Type
3 Coronary Drug-Eluting Stent Demand
4 Coronary Bare-Metal Stent Demand
5 Peripheral Stent Demand by Product Group
6 Endovascular Stent-Graft Demand
7 Renal & Related Stent Demand
8 Femoral & Related Stent Demand
9 Carotid Stent Demand
10 Stent-Related Implant Demand by Product Group
SECTION VI -- STRUCTURAL CARDIAC IMPLANTS
1 Structural Cardiac Implant Demand by Product Group
2 Heart Valve Implant Demand by Product Group
3 Ventricular Assist Device Demand
4 Implantable Heart Monitor Demand
SECTION VII -- INDUSTRY STRUCTURE
1 Cardiac Implant Sales by Company, 2007
2 Selected Acquisitions & Divestitures
3 Selected Cooperative Agreements
LIST OF CHARTS
SECTION III -- CARDIAC IMPLANT OVERVIEW
1 Cardiovascular Conditions by Type, 2007
2 Cardiac Implant Procedures by Type, 2007
3 Cardiac Implant Demand by Product Group, 2007
4 Cardiac Implant Demand by Indication, 2007
SECTION IV -- PACING DEVICES
1 Pacing Device Demand by Product Group, 2007
2 Pacing Devices Market Share by Company, 2007
SECTION V -- STENTS & RELATED IMPLANTS
1 Stent & Stent-Related Implant Demand by Product Group, 2007
2 Stents & Stent-Related Implant Market Share by Company, 2007
SECTION VI -- STRUCTURAL CARDIAC IMPLANTS
1 Structural Cardiac Implant Demand by Product Group, 2007
2 Structural Cardiac Implant Market Share by Company, 2007
SECTION VII -- INDUSTRY STRUCTURE
1 US Cardiac Implants, Market Share by Company, 2007

To order this report:

US Cardiac Implants Market

http://www.reportlinker.com/p096399/US-Cardiac-Implants-Market.html

More market research reports here!